• Je něco špatně v tomto záznamu ?

European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

D. Cibula, F. Planchamp, D. Fischerova, C. Fotopoulou, C. Kohler, F. Landoni, P. Mathevet, R. Naik, J. Ponce, F. Raspagliesi, A. Rodolakis, K. Tamussino, C. Taskiran, I. Vergote, P. Wimberger, AG. Zahl Eriksson, D. Querleu,

. 2020 ; 30 (1) : 3-14. [pub] -

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023283
E-zdroje Online Plný text

NLK ProQuest Central od 2001-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2001-01-01 do Před 6 měsíci

Odkazy

PubMed 31900285
DOI 10.1136/ijgc-2019-000878
Knihovny.cz E-zdroje

BACKGROUND: Optimizing and ensuring the quality of surgical care is essential to improve the management and outcome of patients with cervical cancer.To develop a list of quality indicators for surgical treatment of cervical cancer that can be used to audit and improve clinical practice. METHODS: Quality indicators were developed using a four-step evaluation process that included a systematic literature search to identify potential quality indicators, in-person meetings of an ad hoc group of international experts, an internal validation process, and external review by a large panel of European clinicians and patient representatives. RESULTS: Fifteen structural, process, and outcome indicators were selected. Using a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are also detailed to define how the indicator will be measured in practice. Each indicator has a target which gives practitioners and health administrators a quantitative basis for improving care and organizational processes. DISCUSSION: Implementation of institutional quality assurance programs can improve quality of care, even in high-volume centers. This set of quality indicators from the European Society of Gynaecological Cancer may be a major instrument to improve the quality of surgical treatment of cervical cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023283
003      
CZ-PrNML
005      
20201214125641.0
007      
ta
008      
201125s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ijgc-2019-000878 $2 doi
035    __
$a (PubMed)31900285
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Cibula, David $u Gynecologic Oncology Center First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic d_cibula@yahoo.com.
245    10
$a European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer / $c D. Cibula, F. Planchamp, D. Fischerova, C. Fotopoulou, C. Kohler, F. Landoni, P. Mathevet, R. Naik, J. Ponce, F. Raspagliesi, A. Rodolakis, K. Tamussino, C. Taskiran, I. Vergote, P. Wimberger, AG. Zahl Eriksson, D. Querleu,
520    9_
$a BACKGROUND: Optimizing and ensuring the quality of surgical care is essential to improve the management and outcome of patients with cervical cancer.To develop a list of quality indicators for surgical treatment of cervical cancer that can be used to audit and improve clinical practice. METHODS: Quality indicators were developed using a four-step evaluation process that included a systematic literature search to identify potential quality indicators, in-person meetings of an ad hoc group of international experts, an internal validation process, and external review by a large panel of European clinicians and patient representatives. RESULTS: Fifteen structural, process, and outcome indicators were selected. Using a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are also detailed to define how the indicator will be measured in practice. Each indicator has a target which gives practitioners and health administrators a quantitative basis for improving care and organizational processes. DISCUSSION: Implementation of institutional quality assurance programs can improve quality of care, even in high-volume centers. This set of quality indicators from the European Society of Gynaecological Cancer may be a major instrument to improve the quality of surgical treatment of cervical cancer.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gynekologické chirurgické výkony $x metody $x normy $7 D013509
650    _2
$a lidé $7 D006801
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a ukazatele kvality zdravotní péče $7 D019984
650    _2
$a chirurgická onkologie $x metody $x normy $7 D000071077
650    _2
$a nádory děložního čípku $x patologie $x chirurgie $7 D002583
655    _2
$a časopisecké články $7 D016428
700    1_
$a Planchamp, François $u Clinical Research Unit, Institut Bergonie, Bordeaux, France.
700    1_
$a Fischerova, Daniela $u Gynecologic Oncology Center First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Fotopoulou, Christina $u Department of Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK.
700    1_
$a Kohler, Christhardt $u Asklepios Hambourg Altona and Department of Gynecology, University of Cologne, Koln, Germany.
700    1_
$a Landoni, Fabio $u Gynaecology, Universita degli Studi di Milano-Bicocca, Monza, Italy.
700    1_
$a Mathevet, Patrice $u Centre Hospitalier Universitaire Vaudois Departement de gynecologie-obstetrique et genetique medicale, Lausanne, Switzerland.
700    1_
$a Naik, Raj $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
700    1_
$a Ponce, Jordi $u University Hospital of Bellvitge (IDIBELL), LHospitalet de Llobregat, Spain.
700    1_
$a Raspagliesi, Francesco $u Gynecologic Oncology, Isituto Tumori Milano, Milan, Italy.
700    1_
$a Rodolakis, Alexandros $u 1st Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athinon, Greece.
700    1_
$a Tamussino, Karl $u Medical University of Graz, Graz, Austria.
700    1_
$a Taskiran, Cagatay $u Department of Obstetrics and Gynecology; Division of Gynecologic Oncology, Gazi University, Ankara, Turkey.
700    1_
$a Vergote, Ignace $u Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, Katholieke Universiteit Leuven, Leuven, Belgium.
700    1_
$a Wimberger, Pauline $u Department of Gynecology and Obstetrics, Technische Universitat Dresden Medizinische Fakultat Carl Gustav Carus, Dresden, Germany.
700    1_
$a Zahl Eriksson, Ane Gerda $u Department of Gynecologic Oncology, Universitetet i Oslo, Oslo, Norway.
700    1_
$a Querleu, Denis $u Clinical Research Unit, Institut Bergonie, Bordeaux, France.
773    0_
$w MED00009896 $t International journal of gynecological cancer : official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 30, č. 1 (2020), s. 3-14
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31900285 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125641 $b ABA008
999    __
$a ok $b bmc $g 1595602 $s 1113959
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 30 $c 1 $d 3-14 $e - $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace